In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Regina Kosiba, RD, LD, discusses key components of nutrition for bariatric surgery recipients, including special populations, such as athletes, patients who are pregnant, and patients receiving...
Regina Kosiba, RD, LD, discusses key components of nutrition for bariatric surgery recipients, including special populations, such as athletes, patients who are pregnant, and patients receiving...
